Reaction Details Report a problem with these data
Target
GTPase KRas [G12D,Q61H]
Ligand
BDBM485677
Substrate
n/a
Meas. Tech.
Inhibition Assay
IC50
>30000±n/a nM
Citation
 Hadari, YR; Carta, L; Schmertzler, M; Williams, TM; Reynolds, CH; Hutcheson, R Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease US Patent  US11000515 Publication Date 5/11/2021 
Target
Name:
GTPase KRas [G12D,Q61H]
Synonyms:
GTPase KRas (G12D, Q61H) | KRAS | KRAS2 | RASK2 | RASK_HUMAN
Type:
Enzyme Catalytic Domain
Mol. Mass.:
21722.64
Organism:
Homo sapiens (Human)
Description:
P01116[G12D,Q61H]
Residue:
189
Sequence:
MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGHEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM
  
Inhibitor
Name:
BDBM485677
Synonyms:
US10940139, Example 02907 | US11000515, Compound TABLE 7.458 | US11213515, TABLE 7.458 | US11541041, Compound Table 7.437
Type:
Small organic molecule
Emp. Form.:
C13H9N3O3S
Mol. Mass.:
287.294
SMILES:
COC(=O)c1cc2nc(nc(O)c2s1)-c1ccccn1
Structure:
Search PDB for entries with ligand similarity: